Suzanne Demko

445 total citations
5 papers, 259 citations indexed

About

Suzanne Demko is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Suzanne Demko has authored 5 papers receiving a total of 259 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Molecular Biology, 2 papers in Oncology and 1 paper in Genetics. Recurrent topics in Suzanne Demko's work include Advanced Breast Cancer Therapies (1 paper), Cell death mechanisms and regulation (1 paper) and Chronic Lymphocytic Leukemia Research (1 paper). Suzanne Demko is often cited by papers focused on Advanced Breast Cancer Therapies (1 paper), Cell death mechanisms and regulation (1 paper) and Chronic Lymphocytic Leukemia Research (1 paper). Suzanne Demko collaborates with scholars based in United States. Suzanne Demko's co-authors include Patricia Keegan, Richard Pazdur, Kun He, Huanyu Chen, Denise Casey, Whitney S. Helms, Stacy S. Shord, Hong Zhao, Kun He and Thomas M. Herndon and has published in prestigious journals such as Clinical Cancer Research, The Oncologist and Heliyon.

In The Last Decade

Suzanne Demko

5 papers receiving 256 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Suzanne Demko United States	4	113	112	79	40	35	5	259
Mohamed Aziz United States	9	80 0.7×	193 1.7×	122 1.5×	28 0.7×	21 0.6×	15	356
Lauren Harvey United States	6	88 0.8×	179 1.6×	45 0.6×	25 0.6×	20 0.6×	8	258
Carmelo Laface Italy	11	92 0.8×	121 1.1×	47 0.6×	30 0.8×	13 0.4×	34	291
Gabriel N. Waterman United States	7	118 1.0×	187 1.7×	60 0.8×	14 0.3×	19 0.5×	8	310
Edwin Kingsley United States	8	103 0.9×	155 1.4×	50 0.6×	122 3.0×	77 2.2×	25	301
Yuanlin Wu China	11	281 2.5×	118 1.1×	97 1.2×	21 0.5×	11 0.3×	24	469
Vojkan Susulic United States	3	54 0.5×	87 0.8×	100 1.3×	21 0.5×	77 2.2×	3	271
Cécile Déjou France	7	78 0.7×	180 1.6×	257 3.3×	25 0.6×	8 0.2×	9	415
Nathan Denlinger United States	10	76 0.7×	213 1.9×	111 1.4×	55 1.4×	26 0.7×	31	336

Countries citing papers authored by Suzanne Demko

Since Specialization

Citations

This map shows the geographic impact of Suzanne Demko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne Demko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne Demko more than expected).

Fields of papers citing papers by Suzanne Demko

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne Demko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne Demko. The network helps show where Suzanne Demko may publish in the future.

Co-authorship network of co-authors of Suzanne Demko

This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne Demko. A scholar is included among the top collaborators of Suzanne Demko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne Demko. Suzanne Demko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Abdelbaki, Mohamed S, Timothy P. Cripe, Richard Curry, et al.. (2022). An open-label multi-center phase 1 safety study of BXQ-350 in children and young adults with relapsed solid tumors, including recurrent malignant brain tumors. Heliyon. 8(12). e12450–e12450. 2 indexed citations

2.

Bradford, Diana, Suzanne Demko, Susan Jin, et al.. (2020). FDA Accelerated Approval of Pembrolizumab for Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma. The Oncologist. 25(7). e1077–e1082. 24 indexed citations

3.

Casey, Denise, Suzanne Demko, Stacy S. Shord, et al.. (2017). FDA Approval Summary: Sonidegib for Locally Advanced Basal Cell Carcinoma. Clinical Cancer Research. 23(10). 2377–2381. 98 indexed citations

4.

Herndon, Thomas M., Suzanne Demko, Xiaoping Jiang, et al.. (2012). U.S. Food and Drug Administration Approval: Peginterferon-alfa-2b for the Adjuvant Treatment of Patients with Melanoma. The Oncologist. 17(10). 1323–1328. 67 indexed citations

5.

Demko, Suzanne, et al.. (2008). FDA Drug Approval Summary: Alemtuzumab as Single-Agent Treatment for B-Cell Chronic Lymphocytic Leukemia. The Oncologist. 13(2). 167–174. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact